While our study provides valuable insights into the role of sortilin, syndecan-1, and associated proteins in prostate cancer cell metabolism, several limitations need to be addressed by further research, including the use of diverse cell lines, in vivo studies, and clinical validation. This evidence concerns the gene SORT1 and prostate cancer.